You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
陈肇始:致力为香港市民提供充足、安全、有效疫苗
阿思达克 12-21 10:05
食卫局局长陈肇始发表网志,指接种疫苗是预防疾病和挽救生命的一种安全有效方法,一般而言,大部分的疫苗接种都是安全的,接种疫苗後的反应通常轻微而且是暂时的,例如轻微发烧、接种部位红肿或疼痛。部分人士亦可能出现较严重,但一般而言亦较罕见的不良反应。

她指,政府采购疫苗是基於现有科学实据,并以确保为全港市民尽早提供安全及有效的疫苗为目标,并就技术平台及每个技术平台中基本已进入第三期临床实验的候选疫苗,谘询新发现及动物传染病暨疫苗可预防疾病联合科学委员会,以及政府四名防疫抗疫专家顾问的意见,目标采购足够剂量供应最少全港两倍人口,以分散风险并确保有足够的疫苗供应全港市民。

她表示,政府目前预先采购的三款疫苗,分别属於三个不同技术平台中,科研技术开发进展及临床实验均属前列的候选疫苗。政府采购有关疫苗是根据专家就采购策略及候选疫苗给予的意见,以及考虑到疫苗的供应量及时间、物流和储存办法等因素。由於全球就疫苗的竞争十分激烈,预计初期供应会相对紧绌。会继续与其他疫苗制造商商讨采购协议,致力为香港市民尽早提供充足、经证明安全及有效的疫苗。

至於紧急使用新冠疫苗的法律责任问题,政府正在参考国际间就有关公共卫生紧急事故下使用新近研发的疫苗的做法,以制定恰当安排。界定及厘清紧急使用新冠疫苗的法律责任,会有助本港尽早获得符合安全性及有效性要求的新冠疫苗,但并不代表免除药厂对於疫苗的所有相关责任(包括品质保证等)。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account